Bloom Syndrome
Alecia M. Thompson
Dr. Thompson-Branch's research has focused on the role of cytokines in bronchopulmonary dysplasia and use of ultrasound to diagnose necrotizing enterocolitis.
<p>With an emphasis on general pediatrics and neonatology, Dr. Thompson completed her residency at NYU Medical Center in 2007 and fellowship at Yale-New Haven Hospital in 2010. During her fellowship, Dr. Thompson also audited the Robert Wood Johnson Clinical Scholars Program, with an interest in performing clinical research. Her research has focused on the role of cytokines in bronchopulmonary dysplasia and use of ultrasound to diagnose necrotizing enterocolitis. She plans to conduct research on the use of near-infrared spectroscopy to delineate central nervous system pathology in preterm infants and predict short-term neurologic outcomes.</p>
Amrita K. Seehra
Alejandra I. Sacasa
Orna Rosen
Ann L. Nguyen
<p>Clinical Education in Neonatology</p>
Neonatal Medicine
Intestinal function and the treatment of fungal infections in infants.
<p>Dr. Ann Nguyen is a board-certified pediatrician and neonatologist who is a clinician specialist in neonatal medicine. She obtained her medical degree from Ross University School of Medicine and completed her training in pediatrics at the Children’s Hospital at Albany Medical Center. Following an additional year as Pediatric Chief Resident, Dr. Nguyen completed a fellowship in neonatal-perinatal medicine at Mattel Children’s Hospital, UCLA Medical Center. Dr. Nguyen’s research interests include intestinal function and the treatment of fungal infections in infants. Dr. Nguyen is a certified instructor for the AAP-AHA Neonatal Resuscitation Program. </p>
Beth N. McLellan
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Beth McLellan graduated with honors from Northwestern University and attended medical school at Wayne State University where she graduated with Alpha Omega Alpha honors. She completed an internship in Internal Medicine at Loyola University Health System and her Dermatology residency at Henry Ford Health System in Detroit where she also served as Chief Resident. She currently is a Professor in the Department of Medicine (Dermatology) and has served as Chief of the Division of Dermatology since 2020.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. McLellan specializes in complex medical Dermatology and has a special interest in Supportive Oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair, and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis as well as successful use of bacterial decolonization for prevention of radiation dermatitis. She has published numerous articles and textbook chapters related to Supportive Oncodermatology and is regularly invited to speak at Dermatology and Oncology conferences for physicians and patients including the annual meeting of the American Academy of Dermatology, ASCO, and Gilda's Club.</span></p>
<p class="MsoNormal" style="margin-bottom: 0in; line-height: normal;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Playing an active role in the Dermatology Residency, Dr. McLellan is the director of resident research and regularly lectures residents and medical students. She has served as a mentor to many residents and students and directs a year-long Oncodermatology research fellowship for medical students taking a year off for research. Interested medical students can learn more about the fellowship here: https://www.einsteinmed.edu/departments/medicine/divisions/dermatology/…;
<div> </div>
<div> </div>
<div> </div>
<p> </p>
Chemotherapy Side Effects
Scalp Cooling
Dr. McLellan specializes in complex medical dermatology and has a special interest in supportive oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.
Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis
<p>Beth N. McLellan, MD, is Chief, Dermatology, Director, Supportive Oncodermatology and Professor, Dermatology at Montefiore Einstein. She specializes in complex medical dermatology and has a special interest in supportive oncodermatology - the treatment of dermatologic diseases in cancer patients. She works closely with oncologists to prevent and treat skin, hair and nail-related side effects due to cancer therapies and is committed to improving the lives of cancer patients.</p><p>After earning her Doctor of Medicine at Wayne State University, Dr. McLellan completed an internship in internal medicine at Loyola University Health System and her dermatology residency at Henry Ford Health System where she also served as chief resident and initiated a supportive oncodermatology clinic. Dr. McLellan received additional oncodermatology training at Memorial Sloan Kettering Cancer Center and at the Institut Gustave Roussy in Paris, France.</p><p>Dr. McLellan leads research examining radiation dermatitis and was the first to describe baseline bacterial colonization as a risk factor for severe radiation dermatitis. Playing an active role in the Montefiore Einstein Dermatology Residency, Dr. McLellan is the Director of Resident Research and regularly lectures residents and medical students at both dermatology and oncology meetings. She has served as a mentor to many residents and students and directs a year long oncodermatology research fellowship for medical students taking a year off for research. Dr. McLellan has published numerous articles and textbook chapters related to supportive oncodermatology and is regularly invited to speak at dermatology and oncology conferences for physicians and patients, including the annual meeting of the American Academy of Dermatology, American Society of Clinical Oncology and Gilda's Club.</p><p>As part of her commitment to treating the whole patient, Dr. McLellan founded the New York Vitiligo Support Group. She has received awards from the Dermatology Foundation.</p>
Julia Karinsky
<p>Julia Karinsky, MD, is a pediatric hospitalist at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Her clinical focus centers on newborn baby care and breastfeeding medicine. Dr. Karinsky believes pediatric hospitalists have a unique opportunity to provide encouragement and education early on to promote sustained breastfeeding.</p><p>After earning her Doctor of Medicine at the Technion Israel Institute of Technology in Haifa, Israel, in 2006, Dr. Karinsky completed her Pediatric Residency at Edmond and Lily Safra Children’s Hospital, Sheba Medical Center in Ramat Gan, Israel, in 2011. She then moved to the United States to complete an additional pediatric residency at Cohen Children’s Medical Center in 2015.</p><p>Dr. Karinsky’s research focuses on quality improvement projects designed to promote safe sleep practices, identify and overcome barriers to integrating safe sleep and breastfeeding in newborn baby care and implement a safe infant sleep and breastfeeding safety bundle.</p><p>Dr. Karinsky is board certified by the American Board of Pediatrics.</p>
Tamara Gomez Kalhan
<p>Tamara Kalhan, MD, FAAP, is Medical Director, Low Birthweight Evaluation and Assessment Program (LEAP) Clinic and Director, Neonatal Education, Wakefield Division at the Children’s Hospital at Montefiore Einstein and Course Director, Medicine Electives in Neonatology and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is on neonatal outcomes for premature infants, low birth weight infants and infants requiring extended Neonatal Intensive Care Unit (NICU) hospitalizations.</p><p>Dr. Kalhan earned her Doctor of Medicine in 2009 at the University of Texas Health Science Center at San Antonio School of Medicine. She completed her pediatric residency in 2012 at St. Louis Children’s Hospital, followed by a fellowship in neonatal-perinatal medicine at Columbia University, where she was Chief Fellow in her final year of training in 2015.</p><p>Dr. Kalhan’s research interests and expertise include improving follow-up care and neonatal outcomes in high-risk infant populations, with an emphasis on early detection of cerebral palsy. She has been co-investigator on research projects and has shared her work through peer-reviewed journals, book chapters, review articles and case reports, abstracts, platform presentations and poster presentations.</p><p>Dr. Kalhan is board certified in General Pediatrics and Neonatal-Perinatal Medicine. She is a member of the American Academy of Pediatrics.</p>
Portia Groening
<p>Portia Groening, MD, FAAP, is Director, Neonatal Transport Program at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Groening’s clinical focus centers on understanding healthcare systems and quality improvement by improving population health, reducing costs, enhancing the patient experience and improving provider satisfaction.</p><p>After earning her Doctor of Medicine at Meharry Medical College in 2003, Dr. Groening completed her pediatrics residency at Schneider Children’s Hospital in 2006. Following this, she completed a neonatal-perinatal medicine fellowship at Maria Fareri Children’s Hospital in 2009.</p><p>Dr. Groening’s research aligns with her clinical expertise, focusing on newborn health. Her work has been published in peer-reviewed publications and she has been principal investigator on research projects.</p><p>Dr. Groening is board certified by the American Board of Pediatrics in General Pediatrics and Neonatal Perinatal Medicine.</p>